Skip to main content
logo
Charming Medical Limited (MCTA)
NASDAQ: MCTA · Real-Time Price · USD
29.11
-0.25 (-0.83%)
Nov 11, 2025, 4:00 PM EDT - Market closed

Charming Medical Financials Overview

Millions USD. Fiscal year is Apr - Mar.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Revenue
4.814.816.226.023.53
Revenue Growth
-11.35%-22.73%3.43%70.37%-
Gross Profit
4.634.636.025.843.48
Operating Income
0.110.111.61.17-0.38
Net Income
-0.02-0.021.20.78-0.31
Earnings Per Share
-0.00-0.000.080.05-0.02
EPS Growth
--54.16%--

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Cash & Investments
7.687.682.942.41.93
Total Debt
0.910.911.160.961.81
Net Cash (Debt)
6.776.771.781.440.12
Net Cash Growth
220.24%279.67%24.01%1100.97%-
Net Cash Per Share
0.420.420.120.090.01

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Operating Cash Flow
-1.22-1.220.430.32.43
Capital Expenditures
-0.34-0.34-0.29-0.21-0.61
Free Cash Flow
-1.56-1.560.140.081.83
Free Cash Flow Growth
--63.10%-95.36%-

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23
Gross Margin
96.36%96.36%96.76%97.17%98.66%
Operating Margin
2.26%2.26%25.71%19.49%-10.73%
Pretax Margin
2.78%2.78%23.07%16.68%-11.91%
Profit Margin
-0.47%-0.47%19.27%12.93%-8.64%
FCF Margin
-32.35%-32.35%2.22%1.41%51.76%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23
PS Ratio
104.89104.89---